328 related articles for article (PubMed ID: 23339765)
1. Radiolabeled iron oxide nanoparticles as dual-modality SPECT/MRI and PET/MRI agents.
Bouziotis P; Psimadas D; Tsotakos T; Stamopoulos D; Tsoukalas C
Curr Top Med Chem; 2012; 12(23):2694-702. PubMed ID: 23339765
[TBL] [Abstract][Full Text] [Related]
2. Nanoprobes for hybrid SPECT/MR molecular imaging.
Misri R; Saatchi K; Häfeli UO
Nanomedicine (Lond); 2012 May; 7(5):719-33. PubMed ID: 22630153
[TBL] [Abstract][Full Text] [Related]
3. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT
Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160
[TBL] [Abstract][Full Text] [Related]
4. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer.
Thomas R; Park IK; Jeong YY
Int J Mol Sci; 2013 Jul; 14(8):15910-30. PubMed ID: 23912234
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of heterodimer radionuclide nanoparticles for magnetic resonance and single-photon emission computed tomography dual-modality imaging.
Zhu J; Zhang B; Tian J; Wang J; Chong Y; Wang X; Deng Y; Tang M; Li Y; Ge C; Pan Y; Gu H
Nanoscale; 2015 Feb; 7(8):3392-5. PubMed ID: 25584713
[TBL] [Abstract][Full Text] [Related]
6. Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging.
Ai F; Ferreira CA; Chen F; Cai W
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):619-30. PubMed ID: 26692551
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
8. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.
Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A
Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381
[TBL] [Abstract][Full Text] [Related]
9. A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging.
Gholami YH; Yuan H; Wilks MQ; Maschmeyer R; Normandin MD; Josephson L; El Fakhri G; Kuncic Z
Int J Nanomedicine; 2020; 15():1253-1266. PubMed ID: 32161456
[TBL] [Abstract][Full Text] [Related]
10. Integrity of (111)In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse.
Wang H; Kumar R; Nagesha D; Duclos RI; Sridhar S; Gatley SJ
Nucl Med Biol; 2015 Jan; 42(1):65-70. PubMed ID: 25277378
[TBL] [Abstract][Full Text] [Related]
11. Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging.
Chakravarty R; Valdovinos HF; Chen F; Lewis CM; Ellison PA; Luo H; Meyerand ME; Nickles RJ; Cai W
Adv Mater; 2014 Aug; 26(30):5119-23. PubMed ID: 24944166
[TBL] [Abstract][Full Text] [Related]
12. Polyaspartic acid coated iron oxide nanoprobes for PET/MRI imaging.
Cowger T; Xie J
Methods Mol Biol; 2013; 1025():225-35. PubMed ID: 23918341
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI.
Karageorgou MA; Bouziotis P; Stiliaris E; Stamopoulos D
Nanomaterials (Basel); 2023 Jan; 13(3):. PubMed ID: 36770463
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe.
Misri R; Meier D; Yung AC; Kozlowski P; Häfeli UO
Nanomedicine; 2012 Aug; 8(6):1007-16. PubMed ID: 22100757
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeled ultra-small Fe
Sun H; Zhang B; Jiang X; Liu H; Deng S; Li Z; Shi H
Nanomedicine (Lond); 2019 Jan; 14(1):5-17. PubMed ID: 30451578
[TBL] [Abstract][Full Text] [Related]
16. Carbon-11 radiolabeling of iron-oxide nanoparticles for dual-modality PET/MR imaging.
Sharma R; Xu Y; Kim SW; Schueller MJ; Alexoff D; Smith SD; Wang W; Schlyer D
Nanoscale; 2013 Aug; 5(16):7476-83. PubMed ID: 23832243
[TBL] [Abstract][Full Text] [Related]
17. Dual nano-sized contrast agents in PET/MRI: a systematic review.
Lahooti A; Sarkar S; Laurent S; Shanehsazzadeh S
Contrast Media Mol Imaging; 2016 Nov; 11(6):428-447. PubMed ID: 28102031
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Preclinical Positron Emission Tomography-Magnetic Resonance Imaging Study of Lymphatic Drainage of Chelator-Free
Madru R; Budassi M; Benveniste H; Lee H; Smith SD; Schlyer DJ; Vaska P; Knutsson L; Strand SE
Cancer Biother Radiopharm; 2018 Aug; 33(6):213-220. PubMed ID: 30036073
[TBL] [Abstract][Full Text] [Related]
19. PET-MR and SPECT-MR multimodality probes: Development and challenges.
Yang CT; Ghosh KK; Padmanabhan P; Langer O; Liu J; Eng DNC; Halldin C; Gulyás B
Theranostics; 2018; 8(22):6210-6232. PubMed ID: 30613293
[TBL] [Abstract][Full Text] [Related]
20. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
